NORCROSS, Ga., June 26,
2024 /PRNewswire/ -- Hi-Tech Pharmaceuticals moves
into its Phase two launch of PRO IGF-1®. Hi-Tech is an enormously
successful sports nutrition company that is known for innovation
and breakthrough products like PRO IGF-1®, which has been shown to
enhance athletic performance, muscle gain, and weight loss.
Hi-Tech Pharmaceuticals takes a great invention (IGF-1 peptide
derived from whey) and makes it a superior product (Pro-IGF-1®).
Our proprietary in-house Liposomal Delivery (LD) system is an
applied coating which allows IGF-1 to readily dissolve in liquids
and ensures the IGF-1 will bypass digestion; will be transported
through the bowel wall; will circulate throughout the body; will
reach the organs and cells; and remain bioavailable at the cellular
level. Liposomal Delivery makes IGF-1 (and other hormones and
nutrients) up to 1,500 % more bioavailable. Without Liposomal
Delivery, IGF-1 loses most of its effectiveness. The Liposomal
Delivery Difference means that IGF-1 products from Hi-Tech do what
they say.
IGF-1 consists of 70 amino acids in a single chain with three
intramolecular disulfide bridges. Insulin-like growth factor type
1—commonly known as IGF-1—is a hormone produced naturally in the
liver and involved in the human body's growth and development.
Pro-IGF-1® is the premier product for serious bodybuilders and
athletes - Over 1000% more IGF-1 than Deer Antler and other IGF
products! This product has been used by both bodybuilders and
professional athletes providing support during extreme exercise or
athletic events. Pro-IGF-1® contains a concentrated source of the
growth factor matrix and co-factors extracted from a proprietary
whey protein and aids recovery and supports the various metabolic
processes that occurs in the body at the cell level.
Just like its better-known relative, human growth hormone (HGH),
insulin-like growth factors (IGFs) are believed to make an
athlete bigger, stronger, and faster. With so many advantages to
athletes at all levels who rely on greater strength and
performance, Pro-IGF-1® offers the precise formulation to
enable the most demanding of athletes to excel through all stages
of physical activity.
Produced naturally in the liver and involved in the body's
growth and development, IGF-1 is needed for growth hormone to
have its effects on muscles and other tissues. The most important
factor to consider is IGF-1's ability to achieve hyperplasia.
Performance-enhancing drugs will help the body through hypertrophy,
which means you are increasing the size of the existing muscle
cells. IGF-1 however, will cause hyperplasia, which means you are
actually increasing the number of cells in the muscle tissue. These
new cells can be utilized through additional training, and use of
Hi-Tech patented DHEA compounds, to make even greater muscle
gains.
About Hi-Tech: Hi-Tech Pharmaceuticals is an
enormously successful company that creates, manufactures and sells
high-quality products. Hi-Tech has been able to increase its market
share in the United States through
its sixteen acquisitions in recent years, which included the
manufacturing bases of Synergy Nutritional Industries in 2005 and
Nittany Pharmaceuticals in Pennsylvania in 2012. Hi-Tech also acquired
many large brands such as: APS Nutrition, ALR, FormuTech Nutrition,
Sports One, Innovative Laboratories, LG Sciences, iForce Nutrition,
Prime Nutrition, Top Secret Nutrition, EAS, and BPI Sports. Hi-Tech
healthcare products based upon its proprietary Cyclosome®
Technology. Hi-Tech's recent strategy has been, and according to
its leaders will continue to be, growth through Merger and
Acquisition activity.
*These statements have not been evaluated by the Food and
Drug Administration. This product is not intended to diagnose,
treat, cure or prevent disease.
Media Contact:
Brandon Schopp
7707979959
379480@email4pr.com
View original
content:https://www.prnewswire.com/news-releases/hi-tech-pharmaceuticals-phase-two-launch-of-revolutionary-pro-igf-1--the-first-successful-production-of-actual-igf-1-in-a-dietary-supplement-302183076.html
SOURCE Hi-Tech Pharmaceuticals, Inc.